These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2924753)

  • 1. Control of differentiation in BC3H1 muscle cells.
    Glaser L; Wice B
    Environ Health Perspect; 1989 Mar; 80():143-8. PubMed ID: 2924753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of muscle differentiation in BC3H1 cells by fibroblast growth factor and vanadate.
    Wice B; Milbrandt J; Glaser L
    J Biol Chem; 1987 Feb; 262(4):1810-7. PubMed ID: 3643214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control by fibroblast growth factor of differentiation in the BC3H1 muscle cell line.
    Lathrop B; Olson E; Glaser L
    J Cell Biol; 1985 May; 100(5):1540-7. PubMed ID: 3988800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of myogenic differentiation by fibroblast growth factor is mediated by position in the G1 phase of the cell cycle.
    Lathrop B; Thomas K; Glaser L
    J Cell Biol; 1985 Dec; 101(6):2194-8. PubMed ID: 4066754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum and fibroblast growth factor inhibit myogenic differentiation through a mechanism dependent on protein synthesis and independent of cell proliferation.
    Spizz G; Roman D; Strauss A; Olson EN
    J Biol Chem; 1986 Jul; 261(20):9483-8. PubMed ID: 3722206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of creatine phosphokinase expression during differentiation of BC3H1 cells.
    Olson EN; Caldwell KL; Gordon JI; Glaser L
    J Biol Chem; 1983 Feb; 258(4):2644-52. PubMed ID: 6337159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth factor control of skeletal muscle differentiation: commitment to terminal differentiation occurs in G1 phase and is repressed by fibroblast growth factor.
    Clegg CH; Linkhart TA; Olwin BB; Hauschka SD
    J Cell Biol; 1987 Aug; 105(2):949-56. PubMed ID: 3624313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple controls for the synthesis of muscle-specific proteins in BC3H1 cells.
    Munson R; Caldwell KL; Glaser L
    J Cell Biol; 1982 Feb; 92(2):350-6. PubMed ID: 7061588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An activated c-Ha-ras allele blocks the induction of muscle-specific genes whose expression is contingent on mitogen withdrawal.
    Payne PA; Olson EN; Hsiau P; Roberts R; Perryman MB; Schneider MD
    Proc Natl Acad Sci U S A; 1987 Dec; 84(24):8956-60. PubMed ID: 3122209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autonomous expression of c-myc in BC3H1 cells partially inhibits but does not prevent myogenic differentiation.
    Schneider MD; Perryman MB; Payne PA; Spizz G; Roberts R; Olson EN
    Mol Cell Biol; 1987 May; 7(5):1973-7. PubMed ID: 3299056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of BC3H1 and primary skeletal muscle cells and the activity of their endogenous insulin-degrading enzyme are inhibited by the same metalloendoprotease inhibitors.
    Kayalar C; Wong WT; Hendrickson L
    J Cell Biochem; 1990 Nov; 44(3):137-51. PubMed ID: 2269683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell cycle withdrawal without concomitant differentiation: analysis of a G1-specific temperature-sensitive murine myoblast cell line.
    Compton RS; Konigsberg IR
    Dev Biol; 1988 Oct; 129(2):476-94. PubMed ID: 3417048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FGF and EGF act synergistically to induce proliferation in BC3H1 myoblasts.
    Kelvin DJ; Simard G; Connolly JA
    J Cell Physiol; 1989 Feb; 138(2):267-72. PubMed ID: 2783932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of fibroblast growth factor on insulin receptor and muscle specific protein gene expression in BC3H-1 myocytes.
    Brunetti A; Goldfine ID
    Mol Endocrinol; 1990 Jun; 4(6):880-5. PubMed ID: 2172794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of mouse myoblast commitment to terminal differentiation by mitogens.
    Linkhart TA; Clegg CH; Hauschka SD
    J Supramol Struct; 1980; 14(4):483-98. PubMed ID: 6454029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential appearance of muscle-specific proteins in myoblasts as a function of time after cell division: evidence for a conserved myoblast differentiation program in skeletal muscle.
    Lin Z; Lu MH; Schultheiss T; Choi J; Holtzer S; DiLullo C; Fischman DA; Holtzer H
    Cell Motil Cytoskeleton; 1994; 29(1):1-19. PubMed ID: 7820854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further characterization of BC3H1 myogenic cells reveals lack of p53 activity and underexpression of several p53 regulated and extracellular matrix-associated gene products.
    Sharp SB; Villalvazo M; Huang M; Gonzalez R; Alarcon I; Bahamonde M; D'Agostin DM; Damle S; Espinosa A; Han SJ; Liu J; Navarro P; Salguero H; Son J; Vu S
    In Vitro Cell Dev Biol Anim; 2002; 38(7):382-93. PubMed ID: 12534338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FGF6 modulates the expression of fibroblast growth factor receptors and myogenic genes in muscle cells.
    Pizette S; Coulier F; Birnbaum D; DeLapeyrière O
    Exp Cell Res; 1996 Apr; 224(1):143-51. PubMed ID: 8612679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ability of adenovirus 5 E1A proteins to suppress differentiation of BC3H1 myoblasts correlates with their binding to a 300 kDa cellular protein.
    Mymryk JS; Lee RW; Bayley ST
    Mol Biol Cell; 1992 Oct; 3(10):1107-15. PubMed ID: 1421568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of acetylcholine receptor alpha-subunit mRNA during differentiation of the BC3H1 muscle cell line.
    Olson EN; Glaser L; Merlie JP; Lindstrom J
    J Biol Chem; 1984 Mar; 259(5):3330-6. PubMed ID: 6699020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.